Jun 5, 2026 08:52AM
Jun 5, 2026 08:50AM
May 27, 2026 07:02AM
May 27, 2026 07:00AM
May 27, 2026 07:00AM
May 18, 2026 07:00AM
May 7, 2026 08:01AM NRx Pharmaceuticals receives FDA clearance for depression trial
May 7, 2026 08:00AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
May 1, 2026 02:30PM
Apr 27, 2026 06:49AM
Apr 22, 2026 07:04AM
Apr 22, 2026 07:00AM NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program
Apr 20, 2026 07:00AM
Apr 15, 2026 07:01AM
Apr 15, 2026 07:00AM
Apr 6, 2026 07:00AM
Apr 6, 2026 07:00AM
Mar 24, 2026 12:58PM
Mar 24, 2026 07:00AM NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Mar 17, 2026 07:00AM
Mar 17, 2026 07:00AM
Mar 16, 2026 07:00AM
Mar 16, 2026 07:00AM
Mar 9, 2026 07:00AM
Mar 4, 2026 06:44AM
Mar 2, 2026 07:03AM NRx Pharmaceuticals names Joshua Brown as chief medical innovation officer
Mar 2, 2026 07:00AM
Feb 27, 2026 09:04AM
Feb 27, 2026 09:00AM
Feb 17, 2026 07:00AM
Jan 21, 2026 07:09AM
Jan 14, 2026 07:04AM
Jan 14, 2026 07:03AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
Jan 5, 2026 06:57AM
Dec 3, 2025 07:00AM
Dec 2, 2025 08:30AM
Dec 2, 2025 08:30AM
Nov 17, 2025 08:03AM
Nov 10, 2025 08:04AM
Nov 10, 2025 08:03AM HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
Oct 16, 2025 06:42AM
Oct 1, 2025 06:56AM
Sep 29, 2025 08:04AM
Sep 29, 2025 08:03AM
Sep 24, 2025 09:25AM
Sep 24, 2025 08:04AM
Sep 24, 2025 08:03AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
Sep 8, 2025 07:01AM

322,870 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All